A A A
DE
Bereichsnavigation

Interim Report for the First Quarter of 2017

Previous
RHÖN-KLINIKUM AG | 05.05.2017

Interim Report for the First Quarter of 2017

New Board of Management tackles main tasks – focus on raising profitability and putting campus concept into practice – outlook for 2017

  • 212,187 patients treated
  • Revenues amount to € 300.1 million
  • EBITDA stands at € 25.5 million
  • Outlook for 2017: Revenues between € 1.20 billion and € 1.23 billion, EBITDA between € 85 million and € 105 million

Bad Neustadt / Saale, 5th May 2017

In the first quarter of the financial year 2017 a total of 212,187 patients were treated in the hospitals of RHÖN-KLINIKUM AG. Revenues for the same period amounted to € 300.1 million with earnings before interest, taxes, depreciation and amortization (EBITDA) standing at € 25.5 million.

Annual General Meeting on 7th June 2017

The Board of Management and Supervisory Board shall propose to this year’s ordinary Annual General Meeting on 7th June 2017 in Frankfurt/Main the distribution of a dividend from the net consolidated profit in the amount of € 0.35 per non-par share. This results in a dividend amount of almost € 23.4 million based on the current number of roughly 67 million shares.

Outlook

For the current financial year 2017 we expect revenues of between € 1.20 billion and € 1.23 billion. This is particularly adversely affected by the latest regulatory legislation, such as lower remuneration for special orthopaedic and cardiological services or the recently introduced discount for lower overheads in the area of additional services.

We expect EBITDA of between € 85 million and € 105 million for 2017. This includes negative effects in a low two-digit million figure for additional expenditure due to the digital transformation of medical processes and one-off burdens because of corporate restructuring. There is, however, also a positive effect from a possible dissolution of the structural financing shortfall at the university hospitals in Giessen and Marburg (UKGM) in the area of separate costing.

“Following the changes in the Board of Management which took place in the first quarter we are now concentrating on improving the profitability of the company as well as going ahead with our projects for the future,” CEO Stephan Holzinger stated. “This is currently our campus concept linking in-patient and out-patient services more closely across various medical areas and also including downstream services, such as rehabilitation and care in the home. State-of-the-art digital technology and our WebEPA+ system for electronic patient records will be in use here. Our campus concept - ideally applied for the first time in our new hospital building in Bad Neustadt - is a completely new approach in providing forward-looking medical care in rural areas and also offers our company viable prospects for growth.”

*********************************************************************************

RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. At five medical sites with a total of about 5,400 beds we offer cutting-edge medical care with a direct link to universities and research institutes. Our top five key areas of treatment are cardiological and coronary disease, neurological disorders, oncology, lung diseases as well as orthopaedic and accident surgery. A total of approx. 16,500 employees work for RHÖN-KLINIKUM AG. Our facilities are located in Bad Berka, Bad Neustadt/Saale, Frankfurt (Oder) and Giessen and Marburg.

 

Your Contact Persons:

RHÖN-KLINIKUM AG

Achim Struchholz
Group Division Head of Corporate Communication
Schlossplatz 1 97616 Bad Neustadt / Saale
Telephone: + 49 - 9771 65-1327
Facsimile: + 49 - 9771 65-1820
E-Mail: kommunikation@rhoen-klinikum-ag.com

Dr. Kai G. Klinger
Group Division Head of Investor Relations & Group Financing
Schlossplatz 1 97616 Bad Neustadt / Saale
Telephone: + 49 - 9771 65-1318
Facsimile: + 49 - 9771 99-1736
E-Mail: ir@rhoen-klinikum-ag.com